These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 33388094)

  • 1. Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19.
    Guo Q; Zhao Y; Li J; Liu J; Yang X; Guo X; Kuang M; Xia H; Zhang Z; Cao L; Luo Y; Bao L; Wang X; Wei X; Deng W; Wang N; Chen L; Chen J; Zhu H; Gao R; Qin C; Wang X; You F
    Cell Host Microbe; 2021 Feb; 29(2):222-235.e4. PubMed ID: 33388094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes.
    Mellett L; Khader SA
    Cytokine Growth Factor Rev; 2022 Feb; 63():90-97. PubMed ID: 34728150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.
    Rocha SM; Fagre AC; Latham AS; Cummings JE; Aboellail TA; Reigan P; Aldaz DA; McDermott CP; Popichak KA; Kading RC; Schountz T; Theise ND; Slayden RA; Tjalkens RB
    Front Immunol; 2022; 13():811430. PubMed ID: 35250984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication.
    Chu J; Xing C; Du Y; Duan T; Liu S; Zhang P; Cheng C; Henley J; Liu X; Qian C; Yin B; Wang HY; Wang RF
    Nat Metab; 2021 Nov; 3(11):1466-1475. PubMed ID: 34580494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lymphoid lineage cells aberrantly expressing alarmins S100A8/A9 in determining the severity of COVID-19.
    Lee J; Kim H; Kim M; Yoon S; Lee S
    Genes Genomics; 2023 Mar; 45(3):337-346. PubMed ID: 36107397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
    Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
    Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
    Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
    Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Canonical Wnt Signaling by the Alarmins S100A8/A9 in Murine Knee Joints: Implications for Osteoarthritis.
    van den Bosch MH; Blom AB; Schelbergen RF; Vogl T; Roth JP; Slöetjes AW; van den Berg WB; van der Kraan PM; van Lent PL
    Arthritis Rheumatol; 2016 Jan; 68(1):152-63. PubMed ID: 26360647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
    Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
    Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short Communication: S100A8 and S100A9, Biomarkers of SARS-CoV-2 Infection and Other Diseases, Suppress HIV Replication in Primary Macrophages.
    Oguariri RM; Brann TW; Adelsberger JW; Chen Q; Goswami S; Mele AR; Imamichi T
    AIDS Res Hum Retroviruses; 2022 May; 38(5):401-405. PubMed ID: 35045753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Levels of Neutrophil Activated Proteins, Alpha-Defensins (DEFA1), Calprotectin (S100A8/A9) and Myeloperoxidase (MPO) Are Associated With Disease Severity in COVID-19 Patients.
    Shrivastava S; Chelluboina S; Jedge P; Doke P; Palkar S; Mishra AC; Arankalle VA
    Front Cell Infect Microbiol; 2021; 11():751232. PubMed ID: 34746027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
    Schuhenn J; Meister TL; Todt D; Bracht T; Schork K; Billaud JN; Elsner C; Heinen N; Karakoese Z; Haid S; Kumar S; Brunotte L; Eisenacher M; Di Y; Lew J; Falzarano D; Chen J; Yuan Z; Pietschmann T; Wiegmann B; Uebner H; Taube C; Le-Trilling VTK; Trilling M; Krawczyk A; Ludwig S; Sitek B; Steinmann E; Dittmer U; Lavender KJ; Sutter K; Pfaender S
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35131898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction.
    Sreejit G; Abdel-Latif A; Athmanathan B; Annabathula R; Dhyani A; Noothi SK; Quaife-Ryan GA; Al-Sharea A; Pernes G; Dragoljevic D; Lal H; Schroder K; Hanaoka BY; Raman C; Grant MB; Hudson JE; Smyth SS; Porrello ER; Murphy AJ; Nagareddy PR
    Circulation; 2020 Mar; 141(13):1080-1094. PubMed ID: 31941367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice.
    Paull JRA; Luscombe CA; Castellarnau A; Heery GP; Bobardt MD; Gallay PA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A8 may govern hyper-inflammation in severe COVID-19.
    Deguchi A; Yamamoto T; Shibata N; Maru Y
    FASEB J; 2021 Sep; 35(9):e21798. PubMed ID: 34339064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
    Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation.
    Xu G; Li Y; Zhang S; Peng H; Wang Y; Li D; Jin T; He Z; Tong Y; Qi C; Wu G; Dong K; Gou J; Liu Y; Xiao T; Qu J; Li L; Liu L; Zhao P; Zhang Z; Yuan J
    Cell Res; 2021 Dec; 31(12):1230-1243. PubMed ID: 34663909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.